Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology

Nanoparticles are designed to deliver therapeutics and diagnostics selectively to tumors. Their size, shape, charge, material, coating, and cargo determine their individual functionalities. A systems approach could help predict the behavior of trillions of nanoparticles interacting in complex tumor...

Full description

Bibliographic Details
Main Authors: Hauert, Sabine (Contributor), Bhatia, Sangeeta N (Author)
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor), Harvard University- (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Bhatia, Sangeeta N. (Contributor)
Format: Article
Language:English
Published: Elsevier, 2015-11-10T13:34:40Z.
Subjects:
Online Access:Get fulltext
Description
Summary:Nanoparticles are designed to deliver therapeutics and diagnostics selectively to tumors. Their size, shape, charge, material, coating, and cargo determine their individual functionalities. A systems approach could help predict the behavior of trillions of nanoparticles interacting in complex tumor environments. Engineering these nanosystems may lead to biomimetic strategies where interactions between nanoparticles and their environment give rise to cooperative behaviors typically seen in natural self-organized systems. Examples include nanoparticles that communicate the location of a tumor to amplify tumor homing or self-assemble and disassemble to optimize nanoparticle transport. The challenge is to discover which nanoparticle designs lead to a desired system behavior. To this end, novel nanomaterials, deep understanding of biology, and computational tools are emerging as the next frontier.
Human Frontier Science Program (Strasbourg, France)
National Institutes of Health (U.S.) (U54CA151884)
MIT-Harvard Center of Cancer Nanotechnology Excellence
National Cancer Institute (U.S.) (Koch Institute Support (Core) Grant P30-CA14051)